Zhejiang Haisen Pharmaceutical Co., Ltd. (SHE:001367)
China flag China · Delayed Price · Currency is CNY
26.16
-0.56 (-2.10%)
Last updated: Aug 20, 2025

SHE:001367 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202019 - 2020
Period Ending
Aug '25 Dec '24 Dec '23 Jan '23 Dec '21 Dec '20 2019 - 2020
3,9322,7962,989---
Upgrade
Market Cap Growth
23.44%-6.46%----
Upgrade
Enterprise Value
2,9631,8322,063---
Upgrade
Last Close Price
26.2318.3019.69---
Upgrade
PE Ratio
31.7122.8228.56---
Upgrade
PS Ratio
7.825.937.52---
Upgrade
PB Ratio
2.812.082.39---
Upgrade
P/TBV Ratio
3.072.112.43---
Upgrade
P/FCF Ratio
419.9127.31128.99---
Upgrade
P/OCF Ratio
23.6416.7337.08---
Upgrade
EV/Sales Ratio
5.893.895.19---
Upgrade
EV/EBITDA Ratio
20.3713.9018.18---
Upgrade
EV/EBIT Ratio
23.2915.7020.45---
Upgrade
EV/FCF Ratio
316.4417.8989.04---
Upgrade
Debt / Equity Ratio
0.010.0100.000.00-
Upgrade
Debt / EBITDA Ratio
0.060.060.000.010.01-
Upgrade
Debt / FCF Ratio
0.090.080.010.010.02-
Upgrade
Asset Turnover
0.330.330.420.810.930.80
Upgrade
Inventory Turnover
2.262.051.572.152.472.25
Upgrade
Quick Ratio
10.529.3312.903.532.462.33
Upgrade
Current Ratio
11.6510.3114.955.353.513.46
Upgrade
Return on Equity (ROE)
9.04%9.45%12.18%25.91%29.36%23.04%
Upgrade
Return on Assets (ROA)
5.01%5.16%6.62%12.59%15.61%12.49%
Upgrade
Return on Capital (ROIC)
5.35%5.61%7.34%15.77%20.45%16.27%
Upgrade
Return on Capital Employed (ROCE)
8.20%8.60%8.00%21.80%28.00%24.80%
Upgrade
Earnings Yield
3.19%4.38%3.50%---
Upgrade
FCF Yield
0.24%3.66%0.78%---
Upgrade
Dividend Yield
0.43%0.63%1.16%---
Upgrade
Payout Ratio
14.63%27.74%-0.66%17.48%85.77%
Upgrade
Buyback Yield / Dilution
-2.99%-9.35%-22.74%0.02%-0.16%
Upgrade
Total Shareholder Return
-2.56%-8.72%-21.58%0.02%-0.16%
Upgrade
Updated Oct 17, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.